Neutralising antibodies against interferon beta in multiple sclerosis.
Mikol
Daniel
D
D000906:Antibodies / Q000097:blood* / Q000276:immunology; D000917:Antibody Formation / Q000276:immunology; D018450:Disease Progression; D006801:Humans; D007155:Immunologic Factors / Q000276:immunology* / Q000627:therapeutic use*; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000276:immunology / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D009500:Neutralization Tests / Q000706:statistics & numerical data; D012107:Research Design / Q000592:standards; D012189:Retrospective Studies; D055502:Secondary Prevention; D016896:Treatment Outcome
D000906:Antibodies; D007155:Immunologic Factors; D016899:Interferon-beta; D000068556:Interferon beta-1a